Hohl Benjamin — SEC Form 4 filings
SEC reporting owner CIK 1882764. 42 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2024-01-31 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 59 legs across 37 filings — 149,118 shares, $4,010,760 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 86.
- Largest priced transaction: sale of 10,000 shares @ $29.58 ($295,839) in Enliven Therapeutics, Inc., filed 2026-03-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | CHIEF FINANCIAL OFFICER | 42 | — | 59 legs · 149,118 sh · $4,010,760 | 86 |
Form 4 filings — Hohl Benjamin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Enliven Therapeutics, Inc. (ELVN) | Sale (S): 4,630 @ $58.35 · Sale (S): 1,388 @ $59.35 | EDGAR |
| 2026-07-21 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 1,072 @ $2.48 · Sale (S): 324 @ $49.97 · Sale (S): 369 @ $51.48 · Sale (S): 2,564 @ $52.32 · Sale (S): 2,638 @ $53.38 · Sale (S): 123 @ $53.87 · +1 more | EDGAR |
| 2026-06-22 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 6,018 @ $2.48 · Sale (S): 1,379 @ $42.78 · Sale (S): 3,401 @ $43.86 · Sale (S): 1,238 @ $44.75 · Option exercise (M): 6,018 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Enliven Therapeutics, Inc. (ELVN) | Sale (S): 10,000 @ $29.58 | EDGAR |
| 2026-02-17 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 13,000 @ $2.48 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $20.40 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $20.63 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,185 @ $20.45 · Sale (S): 65 @ $21.30 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 1,000 @ $2.48 · Sale (S): 1,000 @ $22.66 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,052 @ $20.86 · Sale (S): 198 @ $21.66 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,000 @ $2.48 · Sale (S): 3,000 @ $22.55 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $16.18 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,181 @ $18.68 · Sale (S): 69 @ $19.12 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $21.33 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 1,000 @ $2.48 · Sale (S): 1,000 @ $22.50 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 10,000 @ $2.48 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $20.41 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 171,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 1,000 @ $2.48 · Sale (S): 1,000 @ $22.52 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $21.59 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 13,000 @ $2.48 · Option exercise (M): 1,000 @ $2.48 · Sale (S): 1,000 @ $25.04 · Option exercise (M): 13,000 (derivative) @ $0 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,350 @ $2.48 · Sale (S): 3,350 @ $22.15 · Option exercise (M): 900 @ $2.48 · Sale (S): 900 @ $22.51 · Option exercise (M): 3,350 (derivative) @ $0 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 5,250 @ $2.48 · Sale (S): 4,250 @ $24.78 · Sale (S): 1,000 @ $25.38 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 6,250 @ $2.48 · Sale (S): 5,600 @ $28.49 · Sale (S): 650 @ $29.11 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 814 @ $2.48 · Sale (S): 814 @ $30.00 · Option exercise (M): 814 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 10,218 @ $2.48 · Sale (S): 10,218 @ $27.51 · Option exercise (M): 1,270 @ $2.48 · Sale (S): 1,270 @ $27.51 · Option exercise (M): 10,218 (derivative) @ $0 · Option exercise (M): 1,270 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 521 @ $2.48 · Sale (S): 521 @ $27.54 · Option exercise (M): 521 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 4,250 @ $2.48 · Sale (S): 4,250 @ $24.27 · Option exercise (M): 2,000 @ $2.48 · Sale (S): 2,000 @ $25.33 · Option exercise (M): 4,250 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 4,250 @ $2.48 · Sale (S): 4,250 @ $22.54 · Option exercise (M): 4,250 (derivative) @ $0 | EDGAR |
| 2024-08-02 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 991 @ $2.48 · Sale (S): 991 @ $27.53 · Option exercise (M): 991 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 5,250 @ $2.48 · Sale (S): 5,189 @ $26.67 · Sale (S): 61 @ $27.44 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,000 @ $2.48 · Sale (S): 3,000 @ $25.07 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 4,250 @ $2.48 · Sale (S): 1,280 @ $21.79 · Sale (S): 1,830 @ $22.58 · Sale (S): 1,140 @ $23.43 · Option exercise (M): 4,250 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 4,250 @ $2.48 · Sale (S): 1,906 @ $22.89 · Sale (S): 2,334 @ $23.42 · Sale (S): 10 @ $24.34 · Option exercise (M): 4,250 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 1,000 @ $2.48 · Sale (S): 1,000 @ $22.50 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-05-01 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $16.97 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2024-04-15 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 14,000 @ $2.48 · Sale (S): 3,777 @ $23.88 · Sale (S): 10,223 @ $25.04 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,068 @ $18.22 · Sale (S): 182 @ $18.72 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $16.97 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 185,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Enliven Therapeutics, Inc. (ELVN) | Option exercise (M): 3,250 @ $2.48 · Sale (S): 3,250 @ $15.81 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1882764 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →